drugset / Trial / NCT00465569

A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy

NCT00465569 ↗

Phase 1/2 Completed 20 enrolled Johns Hopkins University Duke University · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if small oral doses of milk protein are safe and effective in decreasing sensitivity to cow's milk in allergic children.

Timeline

Start
2006-08
Primary completion
2008-06
Completion
2008-06

Outcome

Met primary endpoint

paper whereas all patients in the placebo group reacted at 40 mg (P = .0003). PMID 18951617 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject milk protein Unknown 500 mg Oral

Indications

No indication recorded.